In the dynamic landscape of pharmaceutical development, the precise selection of chemical intermediates is paramount. Among these essential building blocks, 5-Fluoro-6-Methylpyridin-2-amine (CAS 110919-71-6) stands out as a compound of significant importance. This pyridine derivative, characterized by its unique fluorine and methyl substitutions, plays a pivotal role in the synthesis of a wide array of Active Pharmaceutical Ingredients (APIs). NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical nature of this intermediate and offers high-quality material to support advancements in drug research and manufacturing.
The utility of 5-Fluoro-6-Methylpyridin-2-amine is deeply rooted in its chemical structure. The presence of fluorine atoms in organic molecules often confers desirable properties such as increased lipophilicity, enhanced metabolic stability, and altered pKa values, all of which can significantly improve a drug candidate's pharmacokinetic profile and therapeutic efficacy. This makes compounds like 5-Fluoro-6-Methylpyridin-2-amine highly sought after in medicinal chemistry for designing novel therapeutics. The ability to procure this intermediate reliably and in high purity is a key factor for pharmaceutical companies aiming to streamline their synthesis processes.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing pharmaceutical manufacturers with intermediates that meet stringent quality standards. Our 5-Fluoro-6-Methylpyridin-2-amine is produced with a purity of ≥99.0%, ensuring minimal impurities that could otherwise complicate downstream reactions or compromise the final API's integrity. This focus on quality is crucial for any manufacturer looking to buy 5-Fluoro-6-Methylpyridin-2-amine for their drug synthesis projects. We understand that consistency and reliability are not just desired but essential for successful drug development.
The application spectrum for this intermediate is broad, spanning various therapeutic areas. It serves as a versatile scaffold, enabling chemists to build complex molecular architectures necessary for targeted drug action. Whether it’s for developing novel treatments for infectious diseases, metabolic disorders, or central nervous system conditions, 5-Fluoro-6-Methylpyridin-2-amine offers a robust starting point. The ability to source such essential pharmaceutical building blocks from trusted suppliers like NINGBO INNO PHARMCHEM CO.,LTD. accelerates the research and development cycle, allowing for quicker progression from laboratory discovery to clinical trials.
For companies seeking to optimize their supply chain for critical pharmaceutical intermediates, partnering with Chinese manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. provides a strategic advantage. The company's expertise in fine chemical manufacturing, coupled with competitive pricing and efficient logistics, makes it an ideal partner. As the pharmaceutical industry continues to innovate, the demand for specialized intermediates like 5-Fluoro-6-Methylpyridin-2-amine will only grow, reinforcing its position as a key component in the global drug manufacturing ecosystem.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.